skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 5,911  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
Material Type:
Article
Add to My Research

Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension

Emerging microbes & infections, 2020-01, Vol.9 (1), p.757-760 [Peer Reviewed Journal]

2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2020 ;2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2020 The Author(s) ;ISSN: 2222-1751 ;EISSN: 2222-1751 ;DOI: 10.1080/22221751.2020.1746200 ;PMID: 32228222

Full text available

2
New Drugs and Therapies in Pulmonary Arterial Hypertension
Material Type:
Article
Add to My Research

New Drugs and Therapies in Pulmonary Arterial Hypertension

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5850 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms24065850 ;PMID: 36982922

Full text available

3
Characteristics, comorbidities and survival analysis of young adults hospitalized with COVID-19 in New York City
Material Type:
Article
Add to My Research

Characteristics, comorbidities and survival analysis of young adults hospitalized with COVID-19 in New York City

PloS one, 2020-12, Vol.15 (12), p.e0243343-e0243343 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Altonen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Altonen et al 2020 Altonen et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0243343 ;PMID: 33315929

Full text available

4
Vitamin C deficiency can lead to pulmonary hypertension: a systematic review of case reports
Material Type:
Article
Add to My Research

Vitamin C deficiency can lead to pulmonary hypertension: a systematic review of case reports

BMC pulmonary medicine, 2024-03, Vol.24 (1), p.140-140 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 1471-2466 ;EISSN: 1471-2466 ;DOI: 10.1186/s12890-024-02941-x ;PMID: 38504249

Full text available

5
The Evolving Management and Treatment Options for Patients with Pulmonary Hypertension: Current Evidence and Challenges
Material Type:
Article
Add to My Research

The Evolving Management and Treatment Options for Patients with Pulmonary Hypertension: Current Evidence and Challenges

Vascular health and risk management, 2023-01, Vol.19, p.103-126 [Peer Reviewed Journal]

2023 Swisher and Weaver. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Swisher and Weaver. 2023 Swisher and Weaver. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S321025 ;PMID: 36895278

Full text available

6
Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review
Material Type:
Article
Add to My Research

Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review

International journal of molecular sciences, 2024-05, Vol.25 (9), p.4941 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms25094941 ;PMID: 38732160

Full text available

7
Disulfiram attenuates hypoxia-induced pulmonary hypertension by inhibiting GSDMD cleavage and pyroptosis in HPASMCs
Material Type:
Article
Add to My Research

Disulfiram attenuates hypoxia-induced pulmonary hypertension by inhibiting GSDMD cleavage and pyroptosis in HPASMCs

Respiratory research, 2022-12, Vol.23 (1), p.353-353 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1465-9921 ;ISSN: 1465-993X ;EISSN: 1465-993X ;DOI: 10.1186/s12931-022-02279-0 ;PMID: 36527086

Full text available

8
Connexin43, A Promising Target to Reduce Cardiac Arrhythmia Burden in Pulmonary Arterial Hypertension
Material Type:
Article
Add to My Research

Connexin43, A Promising Target to Reduce Cardiac Arrhythmia Burden in Pulmonary Arterial Hypertension

International journal of molecular sciences, 2024-03, Vol.25 (6), p.3275 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 by the authors. 2024 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms25063275 ;PMID: 38542257

Full text available

9
Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling
Material Type:
Article
Add to My Research

Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling

International journal of molecular sciences, 2019-01, Vol.20 (2), p.239 [Peer Reviewed Journal]

2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 by the authors. 2019 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms20020239 ;PMID: 30634441

Full text available

10
Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension
Material Type:
Article
Add to My Research

Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension

International journal of molecular sciences, 2021-11, Vol.22 (22), p.12098 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms222212098 ;PMID: 34829978

Full text available

11
Hypertension awareness, treatment, and control and their association with healthcare access in the middle-aged and older Indian population: A nationwide cohort study
Material Type:
Article
Add to My Research

Hypertension awareness, treatment, and control and their association with healthcare access in the middle-aged and older Indian population: A nationwide cohort study

PLoS medicine, 2022-01, Vol.19 (1), p.e1003855-e1003855 [Peer Reviewed Journal]

COPYRIGHT 2022 Public Library of Science ;2022 Lee et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Lee et al 2022 Lee et al ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1003855 ;PMID: 34982770

Full text available

12
New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure
Material Type:
Article
Add to My Research

New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure

PloS one, 2014-04, Vol.9 (4), p.e87845-e87845 [Peer Reviewed Journal]

COPYRIGHT 2014 Public Library of Science ;COPYRIGHT 2014 Public Library of Science ;2014 Úri et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Úri et al 2014 Úri et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0087845 ;PMID: 24691269

Full text available

13
Signal Transduction during Metabolic and Inflammatory Reprogramming in Pulmonary Vascular Remodeling
Material Type:
Article
Add to My Research

Signal Transduction during Metabolic and Inflammatory Reprogramming in Pulmonary Vascular Remodeling

International journal of molecular sciences, 2022-02, Vol.23 (5), p.2410 [Peer Reviewed Journal]

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms23052410 ;PMID: 35269553

Full text available

14
Improving hypertension awareness and management in Vietnam through a community-based model
Material Type:
Article
Add to My Research

Improving hypertension awareness and management in Vietnam through a community-based model

Scientific reports, 2022-11, Vol.12 (1), p.19860-19860, Article 19860 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-022-22546-w ;PMID: 36400798

Full text available

15
Implications of AB0 blood group in hypertensive patients with covid-19
Material Type:
Article
Add to My Research

Implications of AB0 blood group in hypertensive patients with covid-19

BMC cardiovascular disorders, 2020-08, Vol.20 (1), p.373-373, Article 373 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2261 ;EISSN: 1471-2261 ;DOI: 10.1186/s12872-020-01658-z ;PMID: 32799852

Full text available

16
The feasibility of the PAM intervention to support treatment-adherence in people with hypertension in primary care: a randomised clinical controlled trial
Material Type:
Article
Add to My Research

The feasibility of the PAM intervention to support treatment-adherence in people with hypertension in primary care: a randomised clinical controlled trial

Scientific reports, 2021-04, Vol.11 (1), p.8897-8897, Article 8897 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-88170-2 ;PMID: 33903656

Full text available

17
Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru
Material Type:
Article
Add to My Research

Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru

PloS one, 2020-12, Vol.15 (12), p.e0244171-e0244171 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Mejía et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Mejía et al 2020 Mejía et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0244171 ;PMID: 33370364

Full text available

18
Postcardiac injury syndrome caused by radiofrequency catheter ablation of persistent atrial fibrillation: severe pulmonary arterial hypertension with severe tricuspid regurgitation: a rare case report and literature review
Material Type:
Article
Add to My Research

Postcardiac injury syndrome caused by radiofrequency catheter ablation of persistent atrial fibrillation: severe pulmonary arterial hypertension with severe tricuspid regurgitation: a rare case report and literature review

BMC cardiovascular disorders, 2023-04, Vol.23 (1), p.192-192, Article 192 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2261 ;EISSN: 1471-2261 ;DOI: 10.1186/s12872-023-03202-1 ;PMID: 37055734

Full text available

19
Identification of the shared hub gene signatures and molecular mechanisms between HIV-1 and pulmonary arterial hypertension
Material Type:
Article
Add to My Research

Identification of the shared hub gene signatures and molecular mechanisms between HIV-1 and pulmonary arterial hypertension

Scientific reports, 2024-03, Vol.14 (1), p.7048-7048 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-024-55645-x ;PMID: 38528047

Full text available

20
A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway
Material Type:
Article
Add to My Research

A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway

Journal of translational medicine, 2024-02, Vol.22 (1), p.164-164 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1479-5876 ;EISSN: 1479-5876 ;DOI: 10.1186/s12967-023-04741-z ;PMID: 38365806

Full text available

Results 1 - 20 of 5,911  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2013  (7)
  2. 2013 To 2014  (13)
  3. 2015 To 2016  (8)
  4. 2017 To 2019  (15)
  5. After 2019  (5,868)
  6. More options open sub menu

Language 

  1. English  (5,903)
  2. Japanese  (212)
  3. Portuguese  (23)
  4. Spanish  (6)
  5. Norwegian  (4)
  6. French  (3)
  7. Chinese  (3)
  8. Polish  (2)
  9. Turkish  (2)
  10. Korean  (1)
  11. More options open sub menu

Searching Remote Databases, Please Wait